ArticlePathology oncology research : POR2022

Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma.

Yan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.